This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pollex, R. L. Articles by Hegele, R. A. Search for Related Content PubMed PubMed Citation Articles by Pollex, R. L. Articles by Hegele, R. A. Related Collections Clinical genetics Functional genomics Genomics Genetics of cardiovascular disease

(Circulation. 2007;115:3130-3138.)
© 2007 American Heart Association, Inc.

Contemporary Reviews in Cardiovascular Medicine

Copy Number Variation in the Human Genome and Its Implications for Cardiovascular Disease

Rebecca L. Pollex, MSc; Robert A. Hegele, MD, FRCPC

From the Robarts Research Institute and University of Western Ontario, London, Ontario, Canada.

Correspondence to Robert A. Hegele, MD, FRCPC, Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 100 Perth Dr, Room 406, London, Ontario, Canada, N6A 5K8. E-mail hegele@robarts.ca

Key Words: DNA • genetics • genomics • myocardial infarction • risk factors • stroke

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Unlocking the information contained within the human genome will likely advance our understanding of cardiovascular (CV) health and disease by leading to discovery of new molecules, pathways, and networks. A central strategy in genetic studies of CV disease has been to correlate human genomic DNA variation with clinical phenotypes, such as myocardial infarction, heart failure, stroke, and their risk factors, with a range of experimental designs and analytical procedures. The ability to detect genomic differences between individuals is the foundation of this research. Human genomic variation exists in many forms, each of which has unique qualitative and quantitative features. Each form of human genomic variation is composed of many individual variants that occur across the genome. The population frequency of individual variants can range from rare to common. The effect of a specific genomic variant can range from beneficial to neutral to deleterious. To rapidly translate genomic knowledge into diagnosis and treatment of CV disease, it is logical to search for common genomic variants that have a non-neutral impact. In the recent past, one form of genomic variation, the single-nucleotide variant, has dominated the experimental landscape: It is the currency of present genetic CV disease studies. However, recent developments indicate that the focus on single-nucleotide polymorphisms (SNPs) alone will not capture the full range of meaningful human genomic variation, such as a newly characterized and annotated form called copy number variation (CNV).

	Main Varieties of Human Genomic Variation

 
The main forms of human genomic variation are shown in Figure 1. These include SNPs, which are . . . [Full Text of this Article]

This article has been cited by other articles:

				K. L. Lunetta Genetic Association Studies Circulation, July 1, 2008; 118(1): 96 - 101. [Full Text] [PDF]

				S.-M. Brand-Herrmann Where Do We Go for Atherothrombotic Disease Genetics? Stroke, April 1, 2008; 39(4): 1070 - 1075. [Full Text] [PDF]

				R. A. Hegele and M. Dichgans Update on the Genetics of Stroke and Cerebrovascular Disease 2007 Stroke, February 1, 2008; 39(2): 252 - 254. [Full Text] [PDF]

				L. Kuller Is Phenomenology the Best Approach to Health Research? Am. J. Epidemiol., November 15, 2007; 166(10): 1109 - 1115. [Abstract] [Full Text] [PDF]